These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11895376)

  • 1. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
    Shepherd CE; McCann H; Thiel E; Halliday GM
    Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.
    Shepherd CE; Thiel E; McCann H; Halliday GM
    Neurobiol Dis; 2001 Feb; 8(1):136-46. PubMed ID: 11162247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
    Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
    Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease.
    Sampson VL; Morrison JH; Vickers JC
    Exp Neurol; 1997 May; 145(1):295-302. PubMed ID: 9184132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Shimizu S; Tanaka Y; Kanetaka H; Iwamoto T; Abe K
    Neurosci Lett; 2005 May 20-27; 380(1-2):166-9. PubMed ID: 15854771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.
    Bussière T; Giannakopoulos P; Bouras C; Perl DP; Morrison JH; Hof PR
    J Comp Neurol; 2003 Aug; 463(3):281-302. PubMed ID: 12820162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity.
    Sauer J; ffytche DH; Ballard C; Brown RG; Howard R
    Brain; 2006 Jul; 129(Pt 7):1780-8. PubMed ID: 16670180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
    Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
    Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies.
    Ferrer I; Gómez A; Carmona M; Huesa G; Porta S; Riera-Codina M; Biagioli M; Gustincich S; Aso E
    J Alzheimers Dis; 2011; 23(3):537-50. PubMed ID: 21157025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
    Albasanz JL; Dalfó E; Ferrer I; Martín M
    Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.
    Ballmaier M; O'Brien JT; Burton EJ; Thompson PM; Rex DE; Narr KL; McKeith IG; DeLuca H; Toga AW
    Neuroimage; 2004 Sep; 23(1):325-35. PubMed ID: 15325380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.
    Orimo S; Amino T; Itoh Y; Takahashi A; Kojo T; Uchihara T; Tsuchiya K; Mori F; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2005 Jun; 109(6):583-8. PubMed ID: 15933869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia with Lewy bodies.
    McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease.
    Lippa CF; Johnson R; Smith TW
    Ann Neurol; 1998 Jan; 43(1):102-6. PubMed ID: 9450774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
    Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
    Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
    Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.